22 Sep 2020
Lantern Pharma Announces Collaboration and Research Agreement with Fox Chase Cancer Center Focused on Advancing the Development of LP-184 in Pancreatic Cancer
Author: admintech | Filed under: Press ReleaseDALLAS, Sept. 22, 2020 /PRNewswire/ — Lantern Pharma (Nasdaq: LTRN), a clinical-stage biopharma company using its proprietary RADR® artificial intelligence (“A.I.”) platform to improve drug discovery & development and identify patients who will benefit from its targeted oncology…